Number of the records: 1
everolimus
SYS d000068338 LBL 00000cx^^^2200181-^^45^^ 005 20240119195242.0 100 $a 20160101asloy0103 ba0 152 $b mesh 250 $a everolimus $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $8 slo 300 1-
$a 2016 (1997) $8 eng 330 1-
$a A derivative of sirolimus and an inhibitor of TOR SERINE-THREONINE KINASES. It is used to prevent GRAFT REJECTION in heart and kidney transplant patients by blocking cell proliferation signals. It is also an ANTINEOPLASTIC AGENT. $8 eng 450 $a Zortress $5 e $8 eng 450 $a Zortress $5 e $8 slo 450 $a 40-O-(2-hydroxyetyl)-rapamycín $5 e $8 slo 450 $a Afinitor $5 e $8 slo 450 $a Certican $5 e $8 slo 450 $a RAD 001 $5 e $8 slo 450 $a RAD001 $5 e $8 slo 450 $a SDZ RAD $5 e $8 slo 450 $a SDZ-RAD $5 e $8 slo 686 $a D02.540.505.760.500 750 $a Everolimus $8 eng 801 -0
$a SK $b BA006 $c 20160207 801 -2
$a SK $b BA006 $c 20160803 801 -2
$a SK $b BA006 $c 20230523 980 $x M
Number of the records: 1